Form 8-K - Current report:
SEC Accession No. 0000950170-25-064413
Filing Date
2025-05-06
Accepted
2025-05-06 16:01:14
Documents
12
Period of Report
2025-05-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K atyr-20240522.htm   iXBRL 8-K 83679
2 EX-10.1 atyr-ex10_1.htm EX-10.1 138984
  Complete submission text file 0000950170-25-064413.txt   366228

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT atyr-20240522.xsd EX-101.SCH 27024
15 EXTRACTED XBRL INSTANCE DOCUMENT atyr-20240522_htm.xml XML 4554
Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

EIN.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 25917079
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)